Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle

Journal of Clinical Investigation

Volumn 121, Issue 1, 2011, Pages 70-85

  Hnia, Karim ^a,b,c,d,e   Tronchère, Helene ^b,f   Tomczak, Kinga K ^g,h   Amoasii, Leonela ^a,b,c,d,e   Schultz, Patrick ^a,b,c,d   Beggs, Alan H ^g   Payrastre, Bernard ^b,f   Mandel, Jean Louis ^a,b,c,d,e   Laporte, Jocelyn ^a,b,c,d,e  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e l'alimentation et l'Environnement   (France)

^f France   (France)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; DESMIN BINDING PROTEIN; INTERMEDIATE FILAMENT PROTEIN; MYOTUBULARIN 1; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SHAPE; CELLULAR DISTRIBUTION; CENTRONUCLEAR MYOPATHY; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOSKELETON; FETUS; GENE DISRUPTION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; KNOCKOUT MOUSE; MALE; MITOCHONDRION; MOUSE; MUSCLE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; SKELETAL MUSCLE;

ANIMALS; CELL LINE; DESMIN; HUMANS; INTERMEDIATE FILAMENTS; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, MUSCLE; MODELS, MOLECULAR; MUSCLE, SKELETAL; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RECOMBINANT FUSION PROTEINS;

EID: 78650942651     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44021     Document Type: Article

References (45)

1. Yang Y, Bauer C, Strasser G, Wollman R, Julien JP, Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell. 1999;98(2):229-238. (Pubitemid 29344910)
2. Huang JD, et al. Direct interaction of microtubule- and actin-based transport motors. Nature. 1999;397(6716):267-270.
3. Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007;21(13):1581-1597. (Pubitemid 47026362)
4. Toivola DM, Tao GZ, Habtezion A, Liao J, Omary MB. Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 2005;15(11):608-617.
5. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science. 1998;279(5350):514-519.
6. Coulombe PA, Wong P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol. 2004;6(8):699-706.
7. Omary MB, Coulombe PA, McLean WH. Intermediate filament proteins and their associated diseases. N Engl J Med. 2004;351(20):2087-2100.
8. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol. 2000;150(6):1283-1298.
9. Kostareva A, et al. Mice expressing L345P mutant desmin exhibit morphological and functional changes of skeletal and cardiac mitochondria. J Muscle Res Cell Motil. 2008;29(1):25-36.
10. Winter L, Abrahamsberg C, Wiche G. Plectin isoform 1b mediates mitochondrion-intermediate filament network linkage and controls organelle shape. J Cell Biol. 2008;181(6):903-911.
11. Laporte J, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996;13(2):175-182. (Pubitemid 26000437)
12. Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, Mandel JL. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet. 2000;9(15):2223-2229.
13. Taylor GS, Maehama T, Dixon JE. Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci U S A. 2000;97(16):8910-8915.
14. Begley MJ, Taylor GS, Kim SA, Veine DM, Dixon JE, Stuckey JA. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. Mol Cell. 2003;12(6):1391-1402.
15. Buj-Bello A, et al. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet. 2008;17(14):2132-2143.
16. Tronchere H, et al. Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem. 2004;279(8):7304-7312.
17. Laporte J, Liaubet L, Blondeau F, Tronchere H, Mandel JL, Payrastre B. Functional redundancy in the myotubularin family. Biochem Biophys Res Commun. 2002;291(2):305-312.
18. Dowling JJ, et al. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet. 2009;5(2):e1000372.
19. Perrot R, Julien JP. Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments. FASEB J. 2009;23(9):3213-3225.
20. Al-Qusairi L, et al. T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A. 2009;106(44):18763-18768.
21. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev. 2008;22(12):1577-1590.
22. Laporte J, Blondeau F, Gansmuller A, Lutz Y, Vonesch JL, Mandel JL. The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J Cell Sci. 2002;115(pt 15):3105-3117.
23. Biancalana V, et al. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet. 2003;112(2):135-142.
24. Goldfarb LG, Dalakas MC. Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest. 2009;119(7):1806- 1813.
25. Laporte J, et al. MTM1 mutations in X-linked myotubular myopathy. Hum Mutat. 2000;15(5):393-409. (Pubitemid 30331212)
26. Herrmann H, Strelkov SV, Burkhard P, Aebi U. Intermediate filaments: primary determinants of cell architecture and plasticity. J Clin Invest. 2009;119(7):1772-1783.
27. Perng MD, Wen SF, van den IP, Prescott AR, Quinlan RA. Desmin aggregate formation by R120G alphaB-crystallin is caused by altered filament interactions and is dependent upon network status in cells. Mol Biol Cell. 2004;15(5):2335-2346.
28. Vicart P, et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998;20(1):92-95.
29. Bar H, Strelkov SV, Sjoberg G, Aebi U, Herrmann H. The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? J Struct Biol. 2004;148(2):137-152.
30. Colakoglu G, Brown A. Intermediate filaments exchange subunits along their length and elongate by end-to-end annealing. J Cell Biol. 2009;185(5):769-777.
31. Kreplak L, Bar H, Leterrier JF, Herrmann H, Aebi U. Exploring the mechanical behavior of single intermediate filaments. J Mol Biol. 2005;354(3):569-577.
32. Helfand BT, Chang L, Goldman RD. Intermediate filaments are dynamic and motile elements of cellular architecture. J Cell Sci. 2004;117(pt 2):133-141.
33. Chang L, et al. The dynamic properties of intermediate filaments during organelle transport. J Cell Sci. 2009;122(pt 16):2914-2923.
34. Robinson FL, Dixon JE. Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 2006;16(8):403-412.
35. Nicot AS, Laporte J. Endosomal phosphoinositides and human diseases. Traffic. 2008;9(8):1240-1249.
36. Tsujita K, et al. Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol Chem. 2004;279(14):13817-13824. (Pubitemid 38468913)
37. Dang H, Li Z, Skolnik EY, Fares H. Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol Biol Cell. 2004;15(1):189-196.
38. Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999;134(2):206-214.
39. Bar H, et al. Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies. Hum Mutat. 2007;28(4):374-386.
40. Rezniczek GA, et al. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol. 2007;176(7):965-977.
41. Herrmann H, Aebi U. Intermediate filament assembly: fibrillogenesis is driven by decisive dimer-dimer interactions. Curr Opin Struct Biol. 1998;8(2):177-185.
42. Herrmann H, Aebi U. Intermediate filament assembly: temperature sensitivity and polymorphism. Cell Mol Life Sci. 1999;55(11):1416-1431.
43. Herrmann H, Haner M, Brettel M, Ku NO, Aebi U. Characterization of distinct early assembly units of different intermediate filament proteins. J Mol Biol. 1999;286(5):1403-1420.
44. Dorchies OM, et al. Normal innervation and differentiation of X-linked myotubular myopathy muscle cells in a nerve-muscle coculture system. Neuromuscul Disord. 2001;11(8):736-746.
45. Hnia K, et al. L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am J Pathol. 2008;172(6):1509-1519.